Global Health Ltd

Q4 FY27 Earnings Call Analysis

Healthcare Services

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 3margin: Category 3orderbook: Yes
πŸ’°

fundraise

Any current/future new fundraising through debt or equity?

The transcript does not mention any current or planned fundraising through debt or equity. Key points related to financial position: - As of December, the company has a net cash position of around Rs. 600 crores with loans of about Rs. 600 crores and cash of over Rs. 1200 crores. - No guidance or comments were made regarding future fundraising plans. - The company discusses ongoing expansions and investments funded through internal means rather than external fundraising. - Focus remains on operational growth, bed additions, and ramping up newer facilities without indicating the need for external capital raise. - Management did not provide any indication of impending debt or equity issuance during the call.
πŸ—οΈ

capex

Any current/future capex/capital investment/strategic investment?

- Global Health Limited plans a CAPEX of approximately Rs. 1,000 crores for the next fiscal year (FY27), part of a broader Rs. 3,000 crores investment over five years. - The bulk of recent CAPEX was directed toward the Noida facility, with Rs. 600-700 crores spent last year. - FY27 CAPEX is expected to be lower than Rs. 1,000 crores, possibly below Rs. 500 crores, as many new projects are in early stages and major spending is back-ended 2-3 years out. - Incremental capital spending in older units will focus on maintenance and margin improvements, particularly in Noida. - Expansion includes adding beds across multiple locations: 99 at Patna, 110 at Ranchi, 328 at Noida in FY26; further additions possible through brownfield expansions at Lucknow (193 beds), Patna (81 beds), and Noida (222 beds). - Ongoing projects in Guwahati, Mumbai, South Delhi, and Pitampura are progressing through various approval and construction stages.
πŸ“Š

revenue

Future growth expectations in sales/revenue/volumes?

- Developing hospitals (Lucknow, Patna) are showing strong growth with income up 28% in 9 months (excluding Noida) and margin expansion from 30% to 31.1%. - Noida hospital is ramping up as per expectations, with better volume growth since December and plans to add 200 more beds, expected to scale efficiently. - Overall inpatient volumes in developing hospitals increased by 27% YoY, with occupancy at 62% and ARPOB rising 8% to Rs.56,853. - Brownfield expansions potential includes 496 beds across Lucknow, Patna, and Noida, driving medium-term growth with minimal capex. - New specialties and complex work like robotic surgery are being added, contributing to incremental revenue. - ARPOB growth expected to be moderate at 5%-7% annually, reflecting stabilized tariff growth. - Noida's loss peak may be behind, with revenue run rate improving in recent months, indicating positive future earnings momentum.
πŸ“ˆ

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Developing hospitals like Lucknow and Patna are showing strong double-digit revenue and EBITDA growth, with Lucknow margins improving by over 150 bps YoY and stable Patna margins. - Medanta Noida is in ramp-up phase; EBITDA losses are near peak with steady improvement expected, but no specific breakeven guidance provided. - ARPOB growth is expected to moderate to single digits (5%-7% annually) in the next 2-3 years, lower than past double-digit growth. - CAPEX is projected around Rs. 1,000 crores next fiscal year, lower than previous year, mainly maintenance and margin improvement in Noida. - Mature hospitals expected to sustain margins in the 22%-25% range, with no significant structural changes. - Capacity expansions and new specialty additions (robotics, cancer care) are expected to drive volume and revenue growth. - Overall confidence expressed in sustainable value creation from current investments and ramp-up activities.
πŸ“‹

orderbook

Current/ Expected Orderbook/ Pending Orders?

The provided transcript and document pages do not contain specific information regarding the current or expected order book or pending orders for Global Health Limited or Medanta. The discussion primarily covers operational performance, hospital bed capacities, margin profiles, expansion plans, talent acquisition, and financial metrics, but does not mention order book details or pending orders. If you need data on order book or pending orders, it might be found in other sections of the company’s quarterly or annual reports, or specific investor presentations beyond the provided pages.